While mechanical ventilation is a life saver for many critically ill patients, it requires sedation, intubation, and can lead to ventilator associated pneumonia, among other complications. Now Alung Technologies, a Pittsburgh, PA firm, obtained FDA’s Expedited Access Pathway designation for its Hemolung Respiratory Assist System (RAS) that removes carbon dioxide from blood, letting the lungs rest without having to undergo ventilation.
Expedited Access Pathway allows companies to introduce life saving devices quicker, as long as they meet certain unmet needs.
Medgadget chose Alung’s technology as one of the most interesting medical technology developments of 2010 and we’re glad to see it’s coming to clinical use in the U.S.
Flashbacks: The Best of Medgadget 2010…; New Alternatives for Acute Respiratory Therapy…; Hemolung, a Respiratory Dialysis Device, to Start Clinical Trials…; ALung Technologies Hemolung Respiratory Assist Device Cleared in Europe…; Hemolung Respiratory Dialysis System May Soon Replace Ventilation for Critically Ill in Europe…
Product page: Hemolung RAS…